Company intelligence / Profile preview

Xa Bc-Biotech

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

XABC Biotech is a Chinese biotechnology company specializing in the development, manufacturing, and distribution of in vitro diagnostic (IVD) products. The company focuses on rapid diagnostic tests and reagents for infectious diseases, including COVID-19, influenza, and respiratory syncytial virus (RSV). XABC Biotech provides a range of diagnostic solutions including colloidal gold-based rapid tests and fluorescence immunoassay platforms to clinical laboratories and healthcare providers globally. Their business model encompasses the entire value chain from research and development to large-scale production and international sales.

Therapeutic areas: Infectious Diseases
Modalities: DiagnosticAntibody
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Xa Bc-Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xa Bc-Biotech.

Explore the full profile